Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,022.05 -2.95 (-0.29%)

Streaming Delayed Price Updated: 2:44 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

Prediction: This Will Be Wall Street's Next Trillion-Dollar Stock ↗

November 16, 2025

Drugs for weight loss and diabetes are taking Eli Lilly to new heights.

Via The Motley Fool

Maplebear, Tower Semiconductor, And Eli Lilly Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 10-Nov. 14): Are the Others in Your Portfolio? ↗

November 16, 2025

Ten large-cap standouts—including Maplebear, Tower Semiconductor, Eli Lilly, On Holding, Albemarle, and key gold/silver miners—rallied last week on strong earnings, upbeat guidance, analyst upgrades,...

Via Benzinga

Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗

November 15, 2025

A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed to one stock than they realize.

Via Benzinga

Topics ETFs

Druckenmiller Opens Position In Amazon, Closes Microsoft — Here's More Of Duquesne's Biggest Q3 Moves ↗

November 14, 2025

Stanley Druckenmiller's Duquesne Family Office Q3 13F reinforces the firm's reputation for agile and opportunity-driven asset allocation.

Via Benzinga

Government Reopens, AI Stocks Slide On Supply Crunch Fears: This Week In Markets ↗

November 14, 2025

Markets digest U.S. government reopening, hawkish Fed outlook, and AI sell-off as CoreWeave crashes 25%.

Via Benzinga

Topics Artificial Intelligence Economy

Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗

November 14, 2025

While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate.

Via Benzinga

Topics Artificial Intelligence

Novo Nordisk Brings Back Former CEO To Lead Board ↗

November 14, 2025

Meanwhile, Cees de Jong was elected vice chair, replacing Henrik Poulsen, while Britt Meelby Jensen and Stephan Engels were appointed as members of the board at the meeting on Friday.

Via Stocktwits

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...

Via MarketMinute

Topics Artificial Intelligence Economy Intellectual Property

Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since ↗

November 14, 2025

Via MarketBeat

Ozempic Maker Novo Nordisk Faces Board Shakeup ↗

November 14, 2025

Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity drug market.

Via Benzinga

Why Is Everyone Talking About Novo Nordisk Stock? ↗

November 14, 2025

There is hardly a dull moment for the drugmaker these days.

Via The Motley Fool

Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO ↗

November 14, 2025

The board overhaul follows mass resignations triggered by internal disputes over Novo’s direction.

Via Stocktwits

Immuneering (IMRX) Q3 2025 Earnings Transcript ↗

November 13, 2025

Immuneering (IMRX) Q3 2025 Earnings Transcript

Via The Motley Fool

Topics Intellectual Property

Post-Shutdown Data Deluge: Markets Brace for Economic Reckoning as US Government Reopens

November 13, 2025

The United States government has recently emerged from its longest shutdown in history, a 43-day impasse that concluded on November 12, 2025. This protracted closure plunged the nation into an...

Via MarketMinute

Topics Credit Cards Economy World Trade

Mangoceuticals Shares Soar Pre-market After Partnering with Eli Lilly, Novo Nordisk To Sell Obesity Drugs ↗

November 13, 2025

The company has launched two programs, MangoRx Direct and PeachesRx Direct, to provide access to Lilly’s Zepbound and Novo’s Wegovy medicines.

Via Stocktwits

Here Are the Top Growth Healthcare Stocks Every New Investor Should Know ↗

November 13, 2025

These top growth stocks have plenty of room left to run.

Via The Motley Fool

2 Quality Healthcare Stocks That Could Build a Strong Foundation for Beginner Investors ↗

November 13, 2025

Healthcare stocks have plenty to offer new investors.

Via The Motley Fool

1 Incredible Reason to Buy LLY's Stock in November ↗

November 13, 2025

Eli Lilly struck a deal with President Donald Trump last week that could send the stock much higher.

Via The Motley Fool

Topics Government World Trade

Viking Therapeutics Stock Soars To 10-Month High After Canaccord Boost – Retail Traders See It As Next Big Obesity Play ↗

November 13, 2025

Canaccord said Viking’s obesity pipeline is worth far more than the current valuation.

Via Stocktwits

November 12, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

Eli Lilly Soars: A Pharmaceutical Giant's Breakout Fueled by Blockbuster Drugs and Strategic Vision

November 12, 2025

INDIANAPOLIS, IN – November 12, 2025 – Eli Lilly and Company (NYSE: LLY) is experiencing a monumental stock breakout today, sending ripples across the global financial markets. The pharmaceutical...

Via MarketMinute

Could GLP-1 Drugs Make ResMed's CPAP Machines Obsolete? ↗

November 12, 2025

ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

Via The Motley Fool

Mixed Signals on Wall Street: Dow Soars Amidst Government Shutdown Hopes, Tech Giants Stumble

November 12, 2025

New York, NY – November 12, 2025 – The U.S. stock market presented a landscape of diverging fortunes today, as the Dow Jones Industrial Average surged to new record highs, fueled by mounting optimism...

Via MarketMinute

Topics Artificial Intelligence Economy Electric Vehicles

Dow Soars to All-Time Highs as Nation Awaits Crucial House Vote to End Government Shutdown

November 12, 2025

The Dow Jones Industrial Average (DJIA) has surged to unprecedented levels, marking new all-time highs this week, even as the nation holds its breath for a pivotal vote in the U.S. House of...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Dow Surges 400 Points Amid Broad Market Rally; Healthcare and Precious Metals Shine, Barrick Gold Signals Strength

November 12, 2025

New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) soared today, adding over 400 points and hitting fresh record highs as investors rotated back into value and cyclical stocks,...

Via MarketMinute

Topics Economy Stocks

Dow Jones Hits Record Highs, AMD Jumps: What's Moving Markets Wednesday? ↗

November 12, 2025

Blue-chip stocks hit record highs as investors rotate toward old-economy leaders; AMD surges, gold rallies, oil slides on OPEC surplus outlook.

Via Benzinga

Topics Stocks

Forget Recursion Pharmaceuticals: This Could Be an Even Better Artificial Intelligence (AI) Stock ↗

November 12, 2025

Recursion is about to go toe-to-toe with the largest healthcare company.

Via The Motley Fool

Topics Animal Testing Artificial Intelligence

$100 Invested In Eli Lilly 10 Years Ago Would Be Worth This Much Today ↗

November 12, 2025

Via Benzinga

Eli Lilly Drops CVS Health's Drug Benefit Plan For Employees Ahead Of 2026 Switch ↗

November 12, 2025

Eli Lilly to drop CVS Health's drug benefit plan and move to Rightway in 2026 as Novo Nordisk cuts Wegovy prices in India to defend market share.

Via Benzinga

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗

November 12, 2025

Eli Lilly CEO Dave Ricks slams PBM "rent taking" for driving $275 insulin price bubble and explains why he's ready to "disintermediate them."

Via Benzinga

< Previous 1 2

...

18 19 20 21 22 23 24 25 26

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.